tiprankstipranks
Elicera Therapeutics AB (DE:8E8)
FRANKFURT:8E8
Germany Market
Want to see DE:8E8 full AI Analyst Report?

Elicera Therapeutics AB (8E8) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Elicera Therapeutics AB’s (8E8) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Elicera Therapeutics AB is a Sell.
Elicera Therapeutics AB’s (8E8) 20-Day exponential moving average is 0.48, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Sell.
Elicera Therapeutics AB’s (8E8) 50-Day exponential moving average is 0.49, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Sell.

Elicera Therapeutics AB (8E8) Pivot Points

May 01, 2026, 06:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.47
0.47
0.47
0.47
0.47
0.47
0.47
Fibonacci
0.47
0.47
0.47
0.47
0.47
0.47
0.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Elicera Therapeutics AB (8E8) Moving Averages

May 01, 2026, 06:47 AM
Period
Simple
Exponential
MA5
0.48Sell
0.48Sell
MA10
0.48Sell
0.48Sell
MA20
0.48Sell
0.48Sell
MA50
0.49Sell
0.49Sell
MA100
0.49Sell
0.49Sell
MA200
0.50Sell
0.49Sell
Elicera Therapeutics AB’s (8E8) 10-Day exponential moving average is 0.48, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Sell.
Elicera Therapeutics AB’s (8E8) 100-Day exponential moving average is 0.49, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Sell.
Elicera Therapeutics AB’s (8E8) stock price is €0.47 and Elicera Therapeutics AB’s (8E8) 50-day simple moving average is 0.49, creating a Sell signal.
Elicera Therapeutics AB’s (8E8) stock price is €0.47 and Elicera Therapeutics AB’s (8E8) 100-day simple moving average is 0.49, creating a Sell signal.
Elicera Therapeutics AB’s (8E8) stock price is €0.47 and Elicera Therapeutics AB’s (8E8) 200-day simple moving average is 0.50, creating a Sell signal.

Elicera Therapeutics AB (8E8) Technical Indicators

May 01, 2026, 06:47 AM
Name
Value
Implied Action
RSI (14)
45.51
Neutral
STOCH (9,6)
32.55
Neutral
STOCHRSI (14)
48.06
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
8.99
Buy
Williams %R
-67.44
Buy
CCI (14)
-46.24
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
47.95
Neutral
ROC
-4.08
Sell
Elicera Therapeutics AB’s (8E8) Relative Strength Index (RSI) is 45.51, creating a Neutral signal.
Elicera Therapeutics AB’s (8E8) Trend Strength Indicator (ADX) is 8.99, creating a Buy signal.
Elicera Therapeutics AB’s (8E8) Commodity Channel Index (CCI) is -46.24, creating a Neutral signal.
Elicera Therapeutics AB’s (8E8) Price Rate of Change (ROC) is -4.08, creating a Sell signal.

FAQ

Is 8E8 a Buy, Hold, or Sell?
Based on 8E8’s technical indicators, 8E8 is a Strong Sell.
    What is 8E8’s RSI (14)?
    8E8’s RSI (14) is 45.51, which suggests 8E8 is a Neutral.
      What is 8E8’s MACD?
      8E8’s MACD is >-0.01, which suggests 8E8 is a Sell.
        What is 8E8’s 5-day moving average?
        8E8’s 5-day moving average is 0.48, which suggests 8E8 is a Sell.
          What is 8E8’s 20-day moving average?
          8E8 20-day moving average is 0.48, which suggests 8E8 is a Sell.
            What is 8E8’s 50-day moving average?
            8E8’s 50-day moving average is 0.49, which suggests 8E8 is a Sell.
              What is 8E8’s 200-day moving average?
              8E8’s 200-day moving average is 0.50, which suggests 8E8 is a Sell.
                What is 8E8’s Williams % R (14)?
                8E8’s Williams % R (14) is -67.44, which suggests 8E8 is a Buy.
                  What is 8E8’s CCI (14)?
                  8E8’s CCI (14) is -46.24, which suggests 8E8 is a Neutral.
                    What is the share price of Elicera Therapeutics AB?